Foreword |
|
x | |
Contributors |
|
xii | |
Abbreviations |
|
xiv | |
|
Chapter 1 Pain -- definition and classification |
|
|
1 | (4) |
|
|
Chapter 2 Assessing a patient with chronic pain |
|
|
5 | (10) |
|
|
Chapter 3 Physiology of chronic pain |
|
|
15 | (6) |
|
|
Chapter 4 The biopsychosocial model |
|
|
21 | (4) |
|
|
|
25 | (8) |
|
|
|
33 | (4) |
|
|
Chapter 7 Osteoarthritis and osteoporosis |
|
|
37 | (6) |
|
|
Chapter 8 Neuropathic pain |
|
|
43 | (8) |
|
|
Chapter 9 Complex regional pain syndrome |
|
|
51 | (6) |
|
|
|
57 | (6) |
|
|
Chapter 11 Rheumatological considerations |
|
|
63 | (4) |
|
|
Chapter 12 Painful diabetic neuropathy |
|
|
67 | (6) |
|
|
Chapter 13 Post-herpetic neuralgia |
|
|
73 | (8) |
|
|
Chapter 14 Chronic post-surgical pain (CPSP) |
|
|
81 | (4) |
|
|
Chapter 15 Prevention of chronic post-surgical pain |
|
|
85 | (4) |
|
|
Chapter 16 Post-amputation pain |
|
|
89 | (6) |
|
|
Chapter 17 Pain in sickle cell disease |
|
|
95 | (8) |
|
|
|
103 | (4) |
|
|
|
107 | (4) |
|
|
|
111 | (6) |
|
|
|
117 | (4) |
|
|
|
121 | (4) |
|
|
Chapter 23 Injection therapy for chronic pain -- nerve blocks |
|
|
125 | (4) |
|
|
Chapter 24 Injection therapy for chronic pain -- facet interventions |
|
|
129 | (4) |
|
|
Chapter 25 Injection therapy for chronic pain -- radiofrequency procedures |
|
|
133 | (4) |
|
|
Chapter 26 Injection therapy for chronic pain -- epidural injections |
|
|
137 | (6) |
|
|
Chapter 27 Injection therapy for chronic pain -- neurolytic procedures |
|
|
143 | (4) |
|
|
Chapter 28 Injection therapy for chronic pain -- stellate ganglion block |
|
|
147 | (6) |
|
|
Chapter 29 Injection therapy for chronic pain -- lumbar sympathetic block |
|
|
153 | (4) |
|
|
Chapter 30 Injection therapy for chronic pain -- coeliac plexus block |
|
|
157 | (4) |
|
|
Chapter 31 Infusion therapies in chronic pain management |
|
|
161 | (4) |
|
|
Chapter 32 Ultrasound in chronic pain |
|
|
165 | (4) |
|
|
Chapter 33 Radiation -- physics and risks |
|
|
169 | (6) |
|
|
|
Chapter 34 Complementary therapies |
|
|
175 | (4) |
|
|
Chapter 35 Physiotherapy in chronic pain |
|
|
179 | (4) |
|
|
Chapter 36 Psychology in chronic pain |
|
|
183 | (6) |
|
|
Chapter 37 Pain management programmes |
|
|
189 | (4) |
|
|
Chapter 38 Spinal cord stimulators and intrathecal pumps |
|
|
193 | (4) |
|
|
|
Chapter 39 Placebo and pain relief |
|
|
197 | (4) |
|
|
Chapter 40 Pain management in drug abusers |
|
|
201 | (6) |
|
|
Chapter 41 Pain management in intensive care |
|
|
207 | (6) |
|
|
|
Chapter 42 Pain management in special populations |
|
|
213 | (6) |
|
|
Chapter 43 Pharmacology -- simple analgesics -- paracetamol |
|
|
219 | (4) |
|
|
Chapter 44 Pharmacology -- non-steroidal anti-inflammatory drugs (NSAIDs) |
|
|
223 | (12) |
|
|
Chapter 45 Pharmacology -- opioids |
|
|
235 | (10) |
|
Rajinikanth Sundara Rajan |
|
|
|
Chapter 46 Problems of opioid use in chronic pain |
|
|
245 | (4) |
|
|
Chapter 47 Pharmacology -- gabapentinoids |
|
|
249 | (6) |
|
|
Chapter 48 Pharmacology -- other anti-neuropathic agents |
|
|
255 | (8) |
|
|
|
Chapter 49 Pharmacology -- local anaesthetics |
|
|
263 | (8) |
|
|
|
Chapter 50 Pharmacology -- topical agents |
|
|
271 | (10) |
|
|
|
Chapter 51 Pharmacology -- steroids |
|
|
281 | (4) |
|
|
Chapter 52 Pharmacology of other medications -- alpha-2 agonists, NMDA antagonists, muscle relaxants and others |
|
|
285 | (4) |
|
|
Chapter 53 National guidelines in chronic pain |
|
|
289 | (12) |
|
|
Chapter 54 Guidance for primary care clinicians |
|
|
301 | (2) |
|
|
|
|
Chapter 55 Pain management in difficult times (COVID-19) |
|
|
303 | (4) |
|
Index |
|
307 | |